Close

New Bioscience Report Shows Record-Breaking Economic Impact, Accelerated Venture Capital Investment & Job Growth

Jun 4 2018
BIO’s latest report shows that the U.S. bioscience industry has reached record setting annual economic impact, venture capital investment and job growth numbers. Among U.S. technology sectors, the bioscience industry is a leading economic driver and job generator across the U.S., with job growth in 41 states.

New Report Shows Substantial Economic Costs of Chinese Delays on Ag-Biotech Approvals

May 30 2018
Washington, D.C. (May 30, 2018) – Persistent delays in China’s ag-biotech regulatory system slows U.S. farmers’ access to new biotechnology products and costs the U.S. economy tens of thousands of jobs and billions in economic output, according to a new study released today by Informa’s Agribusiness Consulting Group (Informa). 

BIO Announces Renewable Chemicals Programming for 2018 World Congress

May 25 2018
The Biotechnology Innovation Organization (BIO) today announced programming information for renewable chemicals at the 2018 BIO World Congress on Industrial Biotechnology. Programming will consist of four breakout sessions on Tuesday, July 17, covering all aspects of renewable chemicals. Companies profiled in BIO’s 2018 “Renewable Chemical Platforms Building the Biobased Economy” will present renewable chemical innovations and the development of new biobased materials and biopolymers. 

Biotech Leader Testifies Before House Capital Markets Subcommittee

May 23 2018
Washington, DC (May 23, 2018) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House of Representatives Committee on Financial Services, Subcommittee on Capital Markets, Securities, and Investment. Hahn serves as the Co-Chair of BIO’s Finance & Tax Committee.

Biotech in Our Backyard Panel to Highlight Agricultural Innovation in New England Region

May 23 2018
Washington, D.C. (May 23, 2018) - Even with the abundance of high-profile international companies that will converge in Boston for the 2018 BIO International Convention, it’s difficult to overstate the work that is being done in Boston’s backyard. The New England region is one of the top life sciences clusters in the world, with Boston being home to many bioscience companies. 

BIO 2018 to Feature Rob Reiner as Keynote Speaker

May 21 2018
Aactor, director and advocate Rob Reiner will deliver a keynote address at the 2018 BIO International Convention, the world’s premier life sciences event being held in Boston, June 4-7. Reiner’s family story of drug addiction reinforces the urgent need for biotechnology innovation in pain management

Food Evolution Writer/Producer Trace Sheehan to Keynote Food & Ag Program at BIO Int’l Convention

May 16 2018
Washington, D.C. (May 16, 2018) – Trace Sheehan, writer and producer of the highly-acclaimed documentary film Food Evolution, will be a keynote speaker at BIO’s International Convention in Boston, the Biotechnology Innovation Organization (BIO) announced today.

BIO Statement on Trump Administration’s Plan to Lower Drug Costs

May 11 2018
“We have concerns that some of the ideas proposed today could, if adopted, hurt patient access to the medicines they need …”

BIO’s Statement on PTO’s Proposed Changes to the Claim Construction Standard for PTAB Proceedings

May 9 2018

Washington, D.C. (May 9, 2018) – Biotechnology Innovation Organization President for Advocacy, Law & Public Policy Tom DiLenge today issued the following statement in response to the U.S....

BIO Thanks President Trump for Rejecting RIN Cap, Supporting E15

May 8 2018
BIO thanked President Trump and Senators Charles Grassley (R-IA) and Joni Ernst (R-IA) for rejecting a price cap on Renewable Identification Numbers (RINs) and working to provide regulatory relief to enable year-round sales of E15.